The European Medicines Agency (EMA) says that the report from the research group at Oslo Rikshospitalet on the connection between AstraZeneca vaccine and blood clots has not been assessed by them.
On Thursday, the EMA gave the vaccine the green light after it has been investigated for possible connections with blood clots. Norwegian researchers, led by Pål André Holme at Rikshospitalet, concluded on Thursday with such a connection.
– We have considered everything that was available to us until yesterday, so if something more has come today, it is not in our basis. But we have assessed the Norwegian conditions before. If there is a study that has come out today, we have not evaluated it yet. But it will be part of our monitoring of the situation. This is a temporary conclusion, says Sabine Strauss, chair of the audit’s safety committee.